Novita Pharmaceuticals, Inc. — Form D/A
Novita Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D amendment with the SEC on 2020-10-16. $2.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2020-10-16
- Form: D/A
- Accession: 0000897069-20-000415
- Industry: Biotechnology
- Exemptions: 06b
- Amount sold: $2.4M
- Investors: 20
- Date of first sale: 2019-09-07
- Security types: debt
- Revenue range: No Revenues
- SEC file number: 021-350763
Issuer
- Name: Novita Pharmaceuticals, Inc.
- CIK: 0001509360
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2010
- Address: 1161 YORK AVE, APT #8C, NEW YORK, NY, 10065
- Phone: (646) 939-5517
Officers, directors & promoters (13)
| Name | Role | Location |
|---|
| Xin-Yun Y Huang | Director | New York, NY |
| Chenjian Jillian Li | Director | New York, NY |
| Christy Y Shue | Director | New York, NY |
| Jue Jillian Zhang | Director | New York, NY |
| Jonathan Jia Zhu | Director | BOSTON, MA |
| David Jillian Moy | Executive Officer | New York, NY |
| Christy Y Shue | Executive Officer | New York, NY |
| Jue Jillian Zhang | Executive Officer | New York, NY |
| Xin-Yun Y Huang | Executive Officer | New York, NY |
| Chenjian Jullian Li | Director | New York, NY |
| David Jullian Moy | Executive Officer | New York, NY |
| Jue Jullian Zhang | Director | New York, NY |
| Jue Jullian Zhang | Executive Officer | New York, NY |
Other filings by this issuer (4)
More